Viewing StudyNCT02682511



Ignite Creation Date: 2024-05-06 @ 8:09 AM
Last Modification Date: 2024-10-26 @ 11:57 AM
Study NCT ID: NCT02682511
Status: RECRUITING
Last Update Posted: 2024-06-06
First Post: 2016-02-08

Brief Title: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis SSc or SSc-associated Pulmonary Arterial Hypertension
Sponsor: Cumberland Pharmaceuticals
Organization: Cumberland Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Autoimmune Diseases
Scleroderma Diffuse
Scleroderma Systemic
Scleroderma Limited
Sclerosis Progressive Systemic
Skin Diseases
Connective Tissue Diseases
Pathologic Processes
Keywords:
Name View
Ifetroban View
Scleroderma View
Systemic Sclerosis View